Submit Deal

Submit Deal

Cover Image Christopher Bath

Christopher Bath

CEO at NORGINE BV

Manager

Deal Bio

Total Deals2

Valued Deals1

Total Value£ 1.53 B

Avg. Deal Size£ 1.53 B

Market Context

Sort

24 Mar 2020|Denmark|Biotechnology

Target: AZANTA A/S

Bidder: NORGINE BV

5 Service Providers

1 Target | 3 Bidder | 1 Vendor

16 Dealmakers

1 Target | 13 Bidder | 2 Vendor

n/a

Value

26 May 2022|Netherlands|Pharmaceuticals

Target: NORGINE BV

Bidder: GOLDMAN SACHS ASSET MANAGEMENT

13 Service Providers

6 Target | 7 Bidder

80 Dealmakers

41 Target | 39 Bidder

£ 1.53 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite